(VIANEWS) – BRT Realty Trust (BRT), LGI Homes (LGIH), Cadence Design Systems (CDNS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. BRT Realty Trust (BRT)
25% sales growth and 15.08% return on equity
BRT is a real estate investment trust that owns, operates and develops multi-family properties.
Earnings Per Share
As for profitability, BRT Realty Trust has a trailing twelve months EPS of $1.86.
PE Ratio
BRT Realty Trust has a trailing twelve months price to earnings ratio of 9.49. Meaning, the purchaser of the share is investing $9.49 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.08%.
Yearly Top and Bottom Value
BRT Realty Trust’s stock is valued at $17.65 at 20:22 EST, way below its 52-week high of $25.67 and above its 52-week low of $16.43.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Mar 23, 2023, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 5.85%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 7.3%, now sitting on 70.55M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
BRT Realty Trust’s EBITDA is 9.4.
2. LGI Homes (LGIH)
19.3% sales growth and 17.75% return on equity
LGI Homes, Inc. designs, constructs, and sells homes in the United States. It offers entry-level homes, such as detached and attached homes, and move-up homes under the LGI Homes brand name; and luxury series homes under the Terrata Homes brand name. As of December 31, 2020, it owned 113 communities. The company serves in Texas, Arizona, Florida, Georgia, New Mexico, Colorado, North Carolina, South Carolina, Washington, Tennessee, Minnesota, Oklahoma, Alabama, California, Oregon, Nevada, West Virginia, Virginia, and Pennsylvania. LGI Homes, Inc. was founded in 2003 and is headquartered in The Woodlands, Texas.
Earnings Per Share
As for profitability, LGI Homes has a trailing twelve months EPS of $11.62.
PE Ratio
LGI Homes has a trailing twelve months price to earnings ratio of 9.94. Meaning, the purchaser of the share is investing $9.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.75%.
3. Cadence Design Systems (CDNS)
12.2% sales growth and 30.01% return on equity
Cadence Design Systems, Inc. provides software, hardware, services, and reusable integrated circuit (IC) design blocks worldwide. The company offers functional verification services, including emulation and prototyping hardware. Its functional verification offering consists of JasperGold, a formal verification platform; Xcelium, a parallel logic simulation platform; Palladium, an enterprise emulation platform; and Protium, a prototyping platform for chip verification. The company also provides digital IC design and sign off products, including Genus logic synthesis and Joules RTL power solutions, as well as Modus software solution to reduce systems-on-chip design-for-test time; physical implementation tools, such as place and route, optimization, and multiple patterning preparation; and Innovus implementation system, a physical implementation system. In addition, it offers custom IC design and simulation products to create schematic and physical representations of circuits down to the transistor level for analog, mixed-signal, custom digital, memory, and radio frequency designs; and system design and analysis products to develop printed circuit boards and IC packages, as well as to analyze electromagnetic, electro-thermal, and other multi-physics effects. Further, the company provides intellectual property (IP) products comprising pre-verified and customizable functional blocks to integrate into customer's ICs; and verification IP with memory models to emulate and model the expected behavior and interaction of standard industry system interface protocols. Additionally, it offers services related to methodology, education, and hosted design solutions, as well as technical support and maintenance services. The company serves 5G communications, aerospace and defense, automotive, industrial and healthcare, mobile, consumer, and hyperscale computing markets. Cadence Design Systems, Inc. was incorporated in 1987 and is headquartered in San Jose, California.
Earnings Per Share
As for profitability, Cadence Design Systems has a trailing twelve months EPS of $3.18.
PE Ratio
Cadence Design Systems has a trailing twelve months price to earnings ratio of 67.7. Meaning, the purchaser of the share is investing $67.7 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.01%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 13.3%, now sitting on 3.68B for the twelve trailing months.
4. Flowers Foods (FLO)
9.2% sales growth and 16% return on equity
Flowers Foods, Inc. produces and markets packaged bakery products in the United States. It offers fresh breads, buns, rolls, snack cakes, and tortillas, as well as frozen breads and rolls under the Nature's Own, Dave's Killer Bread, Wonder, Canyon Bakehouse, Mrs. Freshley's, and Tastykake brand names. The company distributes its products through a direct-store-delivery distribution and a warehouse delivery system, as well as operates 46 bakeries comprising 44 owned and two leased. Its customers include mass merchandisers, supermarkets and other retailers, convenience stores, national and regional restaurants, quick-serve chains, retail in-store bakeries, foodservice distributors, food wholesalers, institutions, dollar stores, and vending companies. The company was formerly known as Flowers Industries and changed its name to Flowers Foods, Inc. in 2001. Flowers Foods, Inc. was founded in 1919 and is headquartered in Thomasville, Georgia.
Earnings Per Share
As for profitability, Flowers Foods has a trailing twelve months EPS of $1.07.
PE Ratio
Flowers Foods has a trailing twelve months price to earnings ratio of 24.29. Meaning, the purchaser of the share is investing $24.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16%.
Yearly Top and Bottom Value
Flowers Foods’s stock is valued at $25.99 at 20:22 EST, way under its 52-week high of $30.16 and above its 52-week low of $24.15.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Mar 1, 2023, the estimated forward annual dividend rate is 0.88 and the estimated forward annual dividend yield is 3.08%.
Previous days news about Flowers Foods(FLO)
- Flowers foods (flo) surpasses Q1 earnings estimates. According to Zacks on Thursday, 18 May, "While Flowers Foods has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
- : wonder bread maker flowers foods shares fall after hours as forecast disappoints, more people dine out. According to MarketWatch on Thursday, 18 May, "Shares of Flowers Foods Inc. fell after hours on Thursday after the maker of Wonder Bread and Dave’s Killer Bread forecast full-year sales that were below Wall Street’s expectations, citing a "slow start to the year" and "softer category demand" following a quarter in which consumers dined out more regularly. "
5. CVS Health (CVS)
7.6% sales growth and 5.42% return on equity
CVS Health Corporation provides health services in the United States. It operates through Health Care Benefits, Pharmacy Services, and Retail/LTC segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
Earnings Per Share
As for profitability, CVS Health has a trailing twelve months EPS of $3.01.
PE Ratio
CVS Health has a trailing twelve months price to earnings ratio of 23.03. Meaning, the purchaser of the share is investing $23.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.42%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
CVS Health’s EBITDA is 0.44.
Yearly Top and Bottom Value
CVS Health’s stock is valued at $69.33 at 20:22 EST, way under its 52-week high of $107.26 and higher than its 52-week low of $68.10.
Moving Average
CVS Health’s value is below its 50-day moving average of $74.44 and way under its 200-day moving average of $90.20.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.8%, now sitting on 329.92B for the twelve trailing months.
